---

Forensic optometry: A new era called bionic eye

---

Review Article

Author Details : Komal Sharma*, Anjali Rawat, Sabeeha Kausar, Naveen Kumar Madishetti, Moin Khan

Volume : 10, Issue : 2, Year : 2024

Article Page : 218-220

https://doi.org/10.18231/j.ijceo.2024.040

Suggest article by email

Get Permission

---

Abstract

The discipline of visual bionics has seen tremendous advancements during the past ten years. The article  provides a full and pertinent account of the work made thus far. The study identifies and analyses the main traits and limitations of the patient studies that have been attempted internationally. Perhaps the biggest hope in the realm of sensory is to give blind people their sight physiology back. There has been and still is significant scepticism among the vision community over the viability of a comparable & Bionic approach to vision.An artificial retina is created to restore photoreceptor function that has been impaired due to retinal degeneration. The artificial eye catches light and transforms it into a digital signal using devices like surveillance footage, desktops and laptops and electrodes. The cerebral cortex receives this electrical signal, which generates a fresh simulation of vision. This is distinct from implanted lenses or low-vision equipment, which aim to improve a person’s current eyesight.The present initiatives seek to supply enough electricity to operate several electrodes safely. New material development and manufacturing techniques will be essential in overcoming these obstacles. This requirement emphasises how interdisciplinary researches and studies are important for human vision; For instance, product researchers are equally crucial as electrical professionals, BTech Bio Tech Professionals and vision specialists in the development for the Bionic or artificial eye.
 

Keywords : Visual bionics, Visual system, Bionic eye devices.

How to cite : Sharma K, Rawat A, Kausar S, Madishetti N K, Khan M, Forensic optometry: A new era called bionic eye. Indian J Clin Exp Ophthalmol 2024;10(2):218-220

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.